Washington Post Publisher Will Lewis Steps Down After Layoffs 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Instagram Outage Disrupts Thousands of U.S. Users 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Dublin, Feb. 17, 2017 -- Research and Markets has announced the addition of the "Regenerative Medicine - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Regenerative Medicine in US$ Million.
The report profiles 52 companies including many key and niche players such as
- AlloSource (US)
- Anika Therapeutics, Inc. (US)
- Bioventus LLC (US)
- DePuy Synthes Companies (US)
- DePuy Synthes Spine, Inc. (US)
- Exactech, Inc. (US)
- Integra LifeSciences Holdings Corp. (US)
- LifeNet Health, Inc. (US)
- Medtronic, plc (Ireland)
- NovaBone Products LLC (US)
- NuVasive, Inc. (US)
- Orthofix International N.V. (Netherlands)
- Osiris Therapeutics, Inc. (US)
- Smith & Nephew plc (UK)
- Stryker Corporation (US)
- Wright Medical Technology, Inc. (US)
- Zimmer Biomet Holdings, Inc. (US)
Key Topics Covered:
1. Outlook
2. Regenerative Medicine A Macro Perspective
3. Bone And Joint Regenerative Medicine An Overview
4. Competitive Landscape
5. Regenerative Medicine In Other Areas
6. Regulatory Environment
7. A Peek Into The Global Orthopedic Industry
8. Product Overview
9. Product Innovations/Introductions
10. Recent Industry Activity
11. Focus On Select Players
12. Global Market Perspective
Total Companies Profiled: 52 (including Divisions/Subsidiaries 54)
- The United States (37)
- Canada (3)
- Japan (1)
- Europe (10)
- Germany (2)
- The United Kingdom (2)
- Rest of Europe (6)
- Asia-Pacific (Excluding Japan) (1)
- Middle East (1)
- Africa (1)
For more information about this report visit http://www.researchandmarkets.com/research/zzvd55/regenerative
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biopharmaceuticals
